Cahill Represents CIBC, Inc. in $1.15 Billion Acquisition Financing for Watson Pharmaceuticals, Inc.
Date: 11/03/06
Cahill represented Canadian Imperial Bank of Commerce, acting through its New York agency, as Administrative Agent in the $1.15 billion acquisition financing of Andrx Corporation by Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. The acquisition now positions Watson Pharmaceuticals, Inc. as the third-largest pharmaceutical company in the United States. The transaction was comprised of a $650,000,000 Term Loan and $500,000,000 Revolver.